Open the map

IDEXX LaboratoriesIDXX

Diagnostics · NASDAQ · USA

$513.14
Up 1.3% todayClose

Down 25.1% this year and −7.0% since June 26, behind the life science sector at +10.7%. IDEXX Laboratories buys from 1 mapped company.

This year
−25.1%
1 year
−19.2%
P/E
35.2
P/S
8.8
P/B
24.9

Price vs the life science sector

since Jun 26IDXXLife science sector, equal weight
IDEXX Laboratories (IDXX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. IDXX: −7.0% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8IDXX −7.0%Sector +10.7% IDEXX Laboratories (IDXX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. IDXX: −7.0% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8IDXX−7.0%Sector+10.7%

Supply chain

1 supplier
SUPPLIERS →→ CUSTOMERSThermo Fisher Scientific (TMO)TMOThermo Fisher Scien…−1.5%None mappedIDXXIDEXX Laborator… Open the full chain →

About IDEXX Laboratories

Vets are the customers. IDEXX sells the analysers that sit in the clinic, runs the reference laboratories that handle samples sent out, and writes the software the practice runs on.

Theme exposure

Veterinary diagnosticsAnimal healthLab software

Products

  • Veterinary diagnostic instruments
  • Reference laboratories
  • Practice software

Competitors

Risks

  • Pet healthcare spending
  • Competition

Same segment: Diagnostics

Tests, imaging and assays that support clinical decision-making. Segment 6 of 8 in the Medicine, pharma & life science value chain.

Compare IDXX

Side by side with the largest companies in the same segment.

See where IDEXX Laboratories sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →